Fujitsu Laboratories Ltd. and Fujitsu Laboratories of America, Inc. today announced the development of a new technology to estimate the transmission performance, and to improve the throughput of optical networks.
The Toyama Prefectural Tourism Association, Toyama Prefectural University, and Fujitsu Limited today announced the joint development of the smartphone application "Discover TOYAMA" for tourists visiting Toyama prefecture, which is available from the Toyama Prefectural Tourism Association beginning today.
Fujitsu Laboratories Ltd. today announced the development of technology to integrate and rapidly analyze NoSQL databases, used for accumulating large volumes of unstructured IoT data, with relational databases, used for data analysis for mission-critical enterprise systems.
Fujitsu Laboratories Ltd. and Fujitsu Laboratories of America, Inc. have developed technology that makes it easy to design, build, and operate virtual network infrastructure that extend across multiple clouds and corporate networks.
Fujitsu today announced that it has received RIKEN's order for the "Deep learning system," which in terms of operations will be one of the largest-scale supercomputers in Japan specializing in AI research. The RIKEN Center for Advanced Intelligence Project will use the new system, scheduled to go online in April 2017, as a platform to accelerate R&D into AI technology.
Fujitsu Limited and Fujitsu Laboratories Ltd. today announced that Fujitsu has been awarded the grand prize of the 26th annual Global Environment Award sponsored by the Fujisankei Communications Group. Fujitsu received this honor for Fujitsu Laboratories' development of a miniature, highly efficient AC adapter that uses gallium nitride (GaN) high electron mobility transistors (HEMT).
Recent biomedical research shows that many serious diseases – in particular cancer – are caused by persistent disruptions of cellular communication processes. These processes use a biochemical reaction called phosphorylation to control the information flow. This biochemical computer is faulty in cancer, and drugs that block rogue phosphorylation reactions have proven effective cancer treatments. However, despite half a century of intense research, discovering these critical phosphorylation reactions is still slow due to the extensive manual effort required.
FDK Corporation and Fujitsu Laboratories Ltd. today announced that they have jointly developed lithium cobalt pyrophosphate (Li2CoP2O7), which has high energy density, for the cathode material of all-solid lithium-ion batteries ("all-solid-state batteries").
Fujitsu Laboratories Ltd. today announced the development of a technology that enables safe and easy use of cloud services through IoT devices using the biometric authentication functionality of smartphones and near-field wireless functionality.
The University of Toronto and Fujitsu Laboratories Ltd. today announced joint development of the world's lowest power referenceless CDR. The newly developed circuit operates with 55% of the power requirements of previous technology for optical modules in Ethernet used for communication between servers and switches in datacenters.
The Beppu Medical Association, Fujitsu Laboratories Ltd., and Fujitsu Limited today announced the development and successful trial of mobile-application control technology that revolutionizes on-site home healthcare work.
Fujitsu Laboratories Ltd. has announced development of the world's first slide-style palm vein authentication technology. This technology is compact enough to be equipped to future tablets and other handheld mobile devices.